V

Vir Biotechnology
D

VIR

7.35000
USD
0.00
(0.00%)
Market Closed
Volume
48,822
EPS
-4
Div Yield
-
P/E
-2
Market Cap
1,012,242,882
OverviewSignalsIdeasNews
Related Instruments
    A
    AAL
    0.220
    (1.32%)
    16.870 USD
    BA
    BA
    0.470
    (0.27%)
    177.430 USD
    BNTX
    BNTX
    1.810
    (1.63%)
    113.050 USD
    CCL
    CCL
    1.630
    (6.47%)
    26.810 USD
    DAL
    DAL
    0.530
    (0.88%)
    60.910 USD
    GSK
    GSK
    0.155
    (0.46%)
    33.595 USD
    MRNA
    MRNA
    -0.200
    (-0.51%)
    39.360 USD
    N
    NCLH
    1.495
    (5.88%)
    26.900 USD
    N
    NVAX
    0.05000
    (0.58%)
    8.72000 USD
    S
    SPCE
    0.13000
    (2.18%)
    6.10000 USD
    U
    UAL
    1.870
    (1.96%)
    97.440 USD
    More
News

Title: Vir Biotechnology

Sector: Healthcare
Industry: Biotechnology
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development,collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.